This comprehensive review synthesizes cutting-edge research on tissue-specific ubiquitination patterns across cancer types, exploring their profound implications for tumor biology and clinical practice.
This article explores the rapidly evolving field of ubiquitination-based prognostic signatures in cancer.
Ubiquitination, a crucial post-translational modification, is profoundly dysregulated across cancer types, influencing tumorigenesis, progression, and therapeutic response.
This article provides a systematic framework for researchers and drug development professionals on validating ubiquitination targets in cancer versus normal tissues.
This article provides a comprehensive guide for researchers and drug development professionals on optimizing proteasome inhibition assays in cancer models.
This article provides a systematic framework for researchers, scientists, and drug development professionals to troubleshoot and optimize E3 ubiquitin ligase functional assays.
This article provides a comprehensive framework for researchers, scientists, and drug development professionals to enhance the reproducibility of their ubiquitination studies.
Deubiquitinases (DUBs) are promising therapeutic targets, but experimental interference poses significant challenges in accurately characterizing their activity and substrate interactions.
This article provides a comprehensive roadmap for researchers, scientists, and drug development professionals aiming to standardize the quantification of ubiquitination across diverse tissue types.
This article addresses the critical challenge of sample heterogeneity in ubiquitination research, a major obstacle to obtaining reproducible and biologically relevant data.